Global TB Vaccines Market Insights and Forecast to 2031

Report ID: 1197242 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 TB Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global TB Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Immunotherapeutic Vaccines
        1.2.3 Booster Vaccines
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global TB Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Private Clinics
        1.3.4 Research Institutes
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global TB Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global TB Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global TB Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global TB Vaccines Sales by Region
        2.4.1 Global TB Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales TB Vaccines by Region (2023-2028)
    2.5 Global TB Vaccines Revenue by Region
        2.5.1 Global TB Vaccines Revenue by Region (2017-2022)
        2.5.2 Global TB Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global TB Vaccines Sales by Manufacturers
        3.1.1 Global Top TB Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global TB Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of TB Vaccines in 2021
    3.2 Global TB Vaccines Revenue by Manufacturers
        3.2.1 Global TB Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global TB Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by TB Vaccines Revenue in 2021
    3.3 Global TB Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global TB Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global TB Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global TB Vaccines Sales by Type
        4.1.1 Global TB Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global TB Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global TB Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global TB Vaccines Revenue by Type
        4.2.1 Global TB Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global TB Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global TB Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global TB Vaccines Price by Type
        4.3.1 Global TB Vaccines Price by Type (2017-2022)
        4.3.2 Global TB Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global TB Vaccines Sales by Application
        5.1.1 Global TB Vaccines Historical Sales by Application (2017-2022)
        5.1.2 Global TB Vaccines Forecasted Sales by Application (2023-2028)
        5.1.3 Global TB Vaccines Sales Market Share by Application (2017-2028)
    5.2 Global TB Vaccines Revenue by Application
        5.2.1 Global TB Vaccines Historical Revenue by Application (2017-2022)
        5.2.2 Global TB Vaccines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global TB Vaccines Revenue Market Share by Application (2017-2028)
    5.3 Global TB Vaccines Price by Application
        5.3.1 Global TB Vaccines Price by Application (2017-2022)
        5.3.2 Global TB Vaccines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America TB Vaccines Market Size by Type
        6.1.1 North America TB Vaccines Sales by Type (2017-2028)
        6.1.2 North America TB Vaccines Revenue by Type (2017-2028)
    6.2 North America TB Vaccines Market Size by Application
        6.2.1 North America TB Vaccines Sales by Application (2017-2028)
        6.2.2 North America TB Vaccines Revenue by Application (2017-2028)
    6.3 North America TB Vaccines Market Size by Country
        6.3.1 North America TB Vaccines Sales by Country (2017-2028)
        6.3.2 North America TB Vaccines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe TB Vaccines Market Size by Type
        7.1.1 Europe TB Vaccines Sales by Type (2017-2028)
        7.1.2 Europe TB Vaccines Revenue by Type (2017-2028)
    7.2 Europe TB Vaccines Market Size by Application
        7.2.1 Europe TB Vaccines Sales by Application (2017-2028)
        7.2.2 Europe TB Vaccines Revenue by Application (2017-2028)
    7.3 Europe TB Vaccines Market Size by Country
        7.3.1 Europe TB Vaccines Sales by Country (2017-2028)
        7.3.2 Europe TB Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific TB Vaccines Market Size by Type
        8.1.1 Asia Pacific TB Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific TB Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific TB Vaccines Market Size by Application
        8.2.1 Asia Pacific TB Vaccines Sales by Application (2017-2028)
        8.2.2 Asia Pacific TB Vaccines Revenue by Application (2017-2028)
    8.3 Asia Pacific TB Vaccines Market Size by Region
        8.3.1 Asia Pacific TB Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific TB Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America TB Vaccines Market Size by Type
        9.1.1 Latin America TB Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America TB Vaccines Revenue by Type (2017-2028)
    9.2 Latin America TB Vaccines Market Size by Application
        9.2.1 Latin America TB Vaccines Sales by Application (2017-2028)
        9.2.2 Latin America TB Vaccines Revenue by Application (2017-2028)
    9.3 Latin America TB Vaccines Market Size by Country
        9.3.1 Latin America TB Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America TB Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa TB Vaccines Market Size by Type
        10.1.1 Middle East and Africa TB Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa TB Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa TB Vaccines Market Size by Application
        10.2.1 Middle East and Africa TB Vaccines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa TB Vaccines Revenue by Application (2017-2028)
    10.3 Middle East and Africa TB Vaccines Market Size by Country
        10.3.1 Middle East and Africa TB Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa TB Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merck & Co.,Inc
        11.1.1 Merck & Co.,Inc Corporation Information
        11.1.2 Merck & Co.,Inc Overview
        11.1.3 Merck & Co.,Inc TB Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merck & Co.,Inc TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merck & Co.,Inc Recent Developments
    11.2 Sanofi Pasteur
        11.2.1 Sanofi Pasteur Corporation Information
        11.2.2 Sanofi Pasteur Overview
        11.2.3 Sanofi Pasteur TB Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Sanofi Pasteur TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sanofi Pasteur Recent Developments
    11.3 Japan BCG Laboratory
        11.3.1 Japan BCG Laboratory Corporation Information
        11.3.2 Japan BCG Laboratory Overview
        11.3.3 Japan BCG Laboratory TB Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Japan BCG Laboratory TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Japan BCG Laboratory Recent Developments
    11.4 China National Biotec Group
        11.4.1 China National Biotec Group Corporation Information
        11.4.2 China National Biotec Group Overview
        11.4.3 China National Biotec Group TB Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 China National Biotec Group TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 China National Biotec Group Recent Developments
    11.5 Serum Institute
        11.5.1 Serum Institute Corporation Information
        11.5.2 Serum Institute Overview
        11.5.3 Serum Institute TB Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Serum Institute TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Serum Institute Recent Developments
    11.6 India Pvt. Ltd
        11.6.1 India Pvt. Ltd Corporation Information
        11.6.2 India Pvt. Ltd Overview
        11.6.3 India Pvt. Ltd TB Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 India Pvt. Ltd TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 India Pvt. Ltd Recent Developments
    11.7 InterVax Ltd
        11.7.1 InterVax Ltd Corporation Information
        11.7.2 InterVax Ltd Overview
        11.7.3 InterVax Ltd TB Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 InterVax Ltd TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 InterVax Ltd Recent Developments
    11.8 GreenSignal
        11.8.1 GreenSignal Corporation Information
        11.8.2 GreenSignal Overview
        11.8.3 GreenSignal TB Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 GreenSignal TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 GreenSignal Recent Developments
    11.9 Bio Pharma Limited
        11.9.1 Bio Pharma Limited Corporation Information
        11.9.2 Bio Pharma Limited Overview
        11.9.3 Bio Pharma Limited TB Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Bio Pharma Limited TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Bio Pharma Limited Recent Developments
    11.10 Statens Serum Institut
        11.10.1 Statens Serum Institut Corporation Information
        11.10.2 Statens Serum Institut Overview
        11.10.3 Statens Serum Institut TB Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Statens Serum Institut TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Statens Serum Institut Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 TB Vaccines Industry Chain Analysis
    12.2 TB Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 TB Vaccines Production Mode & Process
    12.4 TB Vaccines Sales and Marketing
        12.4.1 TB Vaccines Sales Channels
        12.4.2 TB Vaccines Distributors
    12.5 TB Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 TB Vaccines Industry Trends
    13.2 TB Vaccines Market Drivers
    13.3 TB Vaccines Market Challenges
    13.4 TB Vaccines Market Restraints
14 Key Findings in The Global TB Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global TB Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Immunotherapeutic Vaccines
    Table 3. Major Manufacturers of Booster Vaccines
    Table 4. Major Manufacturers of Others
    Table 5. Global TB Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global TB Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global TB Vaccines Sales by Region (2017-2022) & (K Units)
    Table 8. Global TB Vaccines Sales Market Share by Region (2017-2022)
    Table 9. Global TB Vaccines Sales by Region (2023-2028) & (K Units)
    Table 10. Global TB Vaccines Sales Market Share by Region (2023-2028)
    Table 11. Global TB Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global TB Vaccines Revenue Market Share by Region (2017-2022)
    Table 13. Global TB Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global TB Vaccines Revenue Market Share by Region (2023-2028)
    Table 15. Global TB Vaccines Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global TB Vaccines Sales Share by Manufacturers (2017-2022)
    Table 17. Global TB Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global TB Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 19. TB Vaccines Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global TB Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global TB Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Vaccines as of 2021)
    Table 22. TB Vaccines Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers TB Vaccines Product Offered
    Table 24. Date of Manufacturers Enter into TB Vaccines Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global TB Vaccines Sales by Type (2017-2022) & (K Units)
    Table 27. Global TB Vaccines Sales by Type (2023-2028) & (K Units)
    Table 28. Global TB Vaccines Sales Share by Type (2017-2022)
    Table 29. Global TB Vaccines Sales Share by Type (2023-2028)
    Table 30. Global TB Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global TB Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global TB Vaccines Revenue Share by Type (2017-2022)
    Table 33. Global TB Vaccines Revenue Share by Type (2023-2028)
    Table 34. TB Vaccines Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global TB Vaccines Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global TB Vaccines Sales by Application (2017-2022) & (K Units)
    Table 37. Global TB Vaccines Sales by Application (2023-2028) & (K Units)
    Table 38. Global TB Vaccines Sales Share by Application (2017-2022)
    Table 39. Global TB Vaccines Sales Share by Application (2023-2028)
    Table 40. Global TB Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global TB Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global TB Vaccines Revenue Share by Application (2017-2022)
    Table 43. Global TB Vaccines Revenue Share by Application (2023-2028)
    Table 44. TB Vaccines Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global TB Vaccines Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America TB Vaccines Sales by Type (2017-2022) & (K Units)
    Table 47. North America TB Vaccines Sales by Type (2023-2028) & (K Units)
    Table 48. North America TB Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America TB Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America TB Vaccines Sales by Application (2017-2022) & (K Units)
    Table 51. North America TB Vaccines Sales by Application (2023-2028) & (K Units)
    Table 52. North America TB Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America TB Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America TB Vaccines Sales by Country (2017-2022) & (K Units)
    Table 55. North America TB Vaccines Sales by Country (2023-2028) & (K Units)
    Table 56. North America TB Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America TB Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe TB Vaccines Sales by Type (2017-2022) & (K Units)
    Table 59. Europe TB Vaccines Sales by Type (2023-2028) & (K Units)
    Table 60. Europe TB Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe TB Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe TB Vaccines Sales by Application (2017-2022) & (K Units)
    Table 63. Europe TB Vaccines Sales by Application (2023-2028) & (K Units)
    Table 64. Europe TB Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe TB Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe TB Vaccines Sales by Country (2017-2022) & (K Units)
    Table 67. Europe TB Vaccines Sales by Country (2023-2028) & (K Units)
    Table 68. Europe TB Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe TB Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific TB Vaccines Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific TB Vaccines Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific TB Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific TB Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific TB Vaccines Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific TB Vaccines Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific TB Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific TB Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific TB Vaccines Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific TB Vaccines Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific TB Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific TB Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America TB Vaccines Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America TB Vaccines Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America TB Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America TB Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America TB Vaccines Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America TB Vaccines Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America TB Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America TB Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America TB Vaccines Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America TB Vaccines Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America TB Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America TB Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa TB Vaccines Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa TB Vaccines Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa TB Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa TB Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa TB Vaccines Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa TB Vaccines Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa TB Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa TB Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa TB Vaccines Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa TB Vaccines Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa TB Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa TB Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Merck & Co.,Inc Corporation Information
    Table 107. Merck & Co.,Inc Description and Major Businesses
    Table 108. Merck & Co.,Inc TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Merck & Co.,Inc TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Merck & Co.,Inc Recent Developments
    Table 111. Sanofi Pasteur Corporation Information
    Table 112. Sanofi Pasteur Description and Major Businesses
    Table 113. Sanofi Pasteur TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Sanofi Pasteur TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Sanofi Pasteur Recent Developments
    Table 116. Japan BCG Laboratory Corporation Information
    Table 117. Japan BCG Laboratory Description and Major Businesses
    Table 118. Japan BCG Laboratory TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Japan BCG Laboratory TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Japan BCG Laboratory Recent Developments
    Table 121. China National Biotec Group Corporation Information
    Table 122. China National Biotec Group Description and Major Businesses
    Table 123. China National Biotec Group TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. China National Biotec Group TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. China National Biotec Group Recent Developments
    Table 126. Serum Institute Corporation Information
    Table 127. Serum Institute Description and Major Businesses
    Table 128. Serum Institute TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Serum Institute TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Serum Institute Recent Developments
    Table 131. India Pvt. Ltd Corporation Information
    Table 132. India Pvt. Ltd Description and Major Businesses
    Table 133. India Pvt. Ltd TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. India Pvt. Ltd TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. India Pvt. Ltd Recent Developments
    Table 136. InterVax Ltd Corporation Information
    Table 137. InterVax Ltd Description and Major Businesses
    Table 138. InterVax Ltd TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. InterVax Ltd TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. InterVax Ltd Recent Developments
    Table 141. GreenSignal Corporation Information
    Table 142. GreenSignal Description and Major Businesses
    Table 143. GreenSignal TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. GreenSignal TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. GreenSignal Recent Developments
    Table 146. Bio Pharma Limited Corporation Information
    Table 147. Bio Pharma Limited Description and Major Businesses
    Table 148. Bio Pharma Limited TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Bio Pharma Limited TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Bio Pharma Limited Recent Developments
    Table 151. Statens Serum Institut Corporation Information
    Table 152. Statens Serum Institut Description and Major Businesses
    Table 153. Statens Serum Institut TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Statens Serum Institut TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Statens Serum Institut Recent Developments
    Table 156. Key Raw Materials Lists
    Table 157. Raw Materials Key Suppliers Lists
    Table 158. TB Vaccines Distributors List
    Table 159. TB Vaccines Customers List
    Table 160. TB Vaccines Market Trends
    Table 161. TB Vaccines Market Drivers
    Table 162. TB Vaccines Market Challenges
    Table 163. TB Vaccines Market Restraints
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. TB Vaccines Product Picture
    Figure 3. Global TB Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Immunotherapeutic Vaccines Product Picture
    Figure 4. Booster Vaccines Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global TB Vaccines Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Private Clinics
    Figure 9. Research Institutes
    Figure 10. TB Vaccines Report Years Considered
    Figure 11. Global TB Vaccines Sales 2017-2028 (K Units)
    Figure 12. Global TB Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global TB Vaccines Revenue 2017-2028 (US$ Million)
    Figure 14. Global TB Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global TB Vaccines Sales Market Share by Region (2017-2022)
    Figure 16. Global TB Vaccines Sales Market Share by Region (2023-2028)
    Figure 17. North America TB Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 18. North America TB Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe TB Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe TB Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific TB Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific TB Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America TB Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America TB Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa TB Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa TB Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The TB Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of TB Vaccines in the World: Market Share by TB Vaccines Revenue in 2021
    Figure 29. Global TB Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global TB Vaccines Sales Market Share by Type (2017-2028)
    Figure 31. Global TB Vaccines Revenue Market Share by Type (2017-2028)
    Figure 32. Global TB Vaccines Sales Market Share by Application (2017-2028)
    Figure 33. Global TB Vaccines Revenue Market Share by Application (2017-2028)
    Figure 34. North America TB Vaccines Sales Market Share by Type (2017-2028)
    Figure 35. North America TB Vaccines Revenue Market Share by Type (2017-2028)
    Figure 36. North America TB Vaccines Sales Market Share by Application (2017-2028)
    Figure 37. North America TB Vaccines Revenue Market Share by Application (2017-2028)
    Figure 38. North America TB Vaccines Sales Share by Country (2017-2028)
    Figure 39. North America TB Vaccines Revenue Share by Country (2017-2028)
    Figure 40. U.S. TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe TB Vaccines Sales Market Share by Type (2017-2028)
    Figure 43. Europe TB Vaccines Revenue Market Share by Type (2017-2028)
    Figure 44. Europe TB Vaccines Sales Market Share by Application (2017-2028)
    Figure 45. Europe TB Vaccines Revenue Market Share by Application (2017-2028)
    Figure 46. Europe TB Vaccines Sales Share by Country (2017-2028)
    Figure 47. Europe TB Vaccines Revenue Share by Country (2017-2028)
    Figure 48. Germany TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 49. France TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific TB Vaccines Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific TB Vaccines Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific TB Vaccines Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific TB Vaccines Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific TB Vaccines Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific TB Vaccines Revenue Share by Region (2017-2028)
    Figure 59. China TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. India TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America TB Vaccines Sales Market Share by Type (2017-2028)
    Figure 70. Latin America TB Vaccines Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America TB Vaccines Sales Market Share by Application (2017-2028)
    Figure 72. Latin America TB Vaccines Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America TB Vaccines Sales Share by Country (2017-2028)
    Figure 74. Latin America TB Vaccines Revenue Share by Country (2017-2028)
    Figure 75. Mexico TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa TB Vaccines Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa TB Vaccines Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa TB Vaccines Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa TB Vaccines Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa TB Vaccines Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa TB Vaccines Revenue Share by Country (2017-2028)
    Figure 84. Turkey TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE TB Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 87. TB Vaccines Value Chain
    Figure 88. TB Vaccines Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut
Frequently Asked Questions
TB Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
TB Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
TB Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Laboratory Mixers

Laboratory Mixers market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More

Laboratory Furnaces

Laboratory Furnaces market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

Level Sensors

Level Sensors market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More